Abstract
Despite the combined use of surgery and chemoradiotherapy, the poor prognosis of advanced non-smallcell lung cancer (NSCLC) requires the definition of new therapeutic approaches. The presence of T lymphocytes, with peculiar phenotypic, functional and molecular characteristics within the tumour, suggested the possible use of these cells, expanded in vitro, in protocols of adoptive immunotherapy. We have described how a population of oligoclonal T lymphocytes, derived from advanced NSCLC, can be expanded in vitro and has the capability of lysing autologous cancer cells. What is more important, we observed that patients with advanced NSCLC, treated with TIL expanded in vitro and recombinant interleukin-2, seemed to have a disease-free period longer than that of patients treated with conventional chemoradiotherapy. in an attempt to find new sources of specific lymphocytes for immunotherapy, we describe the analysis of the phenotypic, functional and molecular characteristics of T lymphocytes, derived from lymph nodes draining advanced NSCLC. In this paper we show that these cells, have restriction patterns of T cell receptor β chain similar to those detectable in the population of infiltrating T lymphocytes. This finding suggests that T cells derived from draining lymph nodes of advanced NSCLC have peculiar characteristics and can be a suitable source of effector cells for protocols of adoptive immunotherapy in lung cancer treatment.
Key words: Non-small-cell lung carcinoma, Tumour-infiltrating lymphocytes, T cell receptor, Restriction patterns, In vitro expansion
References
- 1.Flug F, Pelicci PG, Bonetti F, Knowles DM, II, Dalla Favera R. T cell receptor gene rearrangements as markers of lineage and clonality in T cell neoplasms. Proc Natl Acad Sci USA. 1985;82:3460. doi: 10.1073/pnas.82.10.3460. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Holmes EC. Postoperative chemotherapy for non-small-cell lung cancer. Chest. 1993;103:30S. doi: 10.1378/chest.103.1_supplement.30s. [DOI] [PubMed] [Google Scholar]
- 3.Melioli G, Ratto GB, Guastella M, Meta M, Biassoni R, Semino C, Casartelli G, Pasquetti W, Catrullo A, Moretta L. Isolation and in vitro expansion of lymphocytes infiltrating non-small cell lung carcinoma: functional and molecular characterization for their use in adoptive immunotherapy. Eur J Cancer. 1994;30:97. doi: 10.1016/s0959-8049(05)80027-9. [DOI] [PubMed] [Google Scholar]
- 4.Moretta A, Pantaleo G, Mingari MC, Cerottini JC. Direct demonstration of the clonogenic potential of every human peripheral blood cell. Clonal analysis of HLA-DR expression and cytolytic activities. J Exp Med. 1983;157:743. doi: 10.1084/jem.157.2.743. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Mountain CF. A new international staging system for lung cancer. Chest. 1986;89:225S. doi: 10.1378/chest.89.4_supplement.225s. [DOI] [PubMed] [Google Scholar]
- 6.Ratto GB, Melioli G, Zino P, Mereu C, Mirabelli S, Fantino G, Ponte M, Minuti P, Verna A, Noceti P, Tassara E, Rovida S (1995) Immunotherapy using tumour infiltrating lymphocytes and interleukin-2 as adjuvant treatment in stage III non-small-cell lung cancer: a pilot study. J Thorac Cardiovasc Surg (in press) [DOI] [PubMed]
- 7.Rosenberg SA, Spiess P, Lafreniere R. A new approach to the adoptive immunotherapy of cancer with tumour infiltrating lymphocytes. Science. 1986;233:1318. doi: 10.1126/science.3489291. [DOI] [PubMed] [Google Scholar]
- 8.Rosenberg SA, Packard BS, Aebersold PM, Solomon D, Topalian SL, Toy ST, et al. Use of tumour infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma: a preliminar report. N Engl J Med. 1988;319:1676. doi: 10.1056/NEJM198812223192527. [DOI] [PubMed] [Google Scholar]
- 9.Sambrook J, Fritsch EF, Maniatis T. Molecular cloning—a laboratory manual. 2nd edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1989. [Google Scholar]
- 10.Yoshikai Y, Anatoniou D, Clark SP, Yanagi Y, Sangster R, Van der Elsen P, Terhorst C, Mak TW. Sequence and expression of transcripts of the human T-cell receptor β-chain genes. Nature. 1984;312:521. doi: 10.1038/312521a0. [DOI] [PubMed] [Google Scholar]
- 11.Yoshino I, Yano T, Yoshikai Y, Murata M, Sugimachi K, Kimura G, Nomoto K. Oligoclonal T lymphocytes infiltrating human lung cancer tissues. Int J Cancer. 1991;47:654. doi: 10.1002/ijc.2910470504. [DOI] [PubMed] [Google Scholar]